156 related articles for article (PubMed ID: 26204041)
1. Namzaric--a combination of 2 old drugs for Alzheimer's disease.
Med Lett Drugs Ther; 2015 Jul; 57(1473):105-6. PubMed ID: 26204041
[No Abstract] [Full Text] [Related]
2. Combination therapy no advantage in Alzheimer's treatment.
Harv Health Lett; 2012 Jun; 37(8):8. PubMed ID: 22774260
[No Abstract] [Full Text] [Related]
3. [Memantine brakes Alzheimer's dementia. The NMDA antagonist is effective in severe cases, too].
MMW Fortschr Med; 2003 May; 145 Suppl 2():21. PubMed ID: 14579479
[No Abstract] [Full Text] [Related]
4. [Progress of dementia medicine: Special reference to Alzheimer's disease].
Utsumi K
Hokkaido Igaku Zasshi; 2014 May; 89(1):21-3. PubMed ID: 25039104
[No Abstract] [Full Text] [Related]
5. Alzheimer's disease: beware of interactions with cholinesterase inhibitors.
Prescrire Int; 2006 Jun; 15(83):103-6. PubMed ID: 16764099
[TBL] [Abstract][Full Text] [Related]
6. Memantine and donepezil: a fixed drug combination for the treatment of moderate to severe Alzheimer's dementia.
Owen RT
Drugs Today (Barc); 2016 Apr; 52(4):239-48. PubMed ID: 27252988
[TBL] [Abstract][Full Text] [Related]
7. A fixed-dose combination of memantine extended-release and donepezil in the treatment of moderate-to-severe Alzheimer's disease.
Deardorff WJ; Grossberg GT
Drug Des Devel Ther; 2016; 10():3267-3279. PubMed ID: 27757016
[TBL] [Abstract][Full Text] [Related]
8. Memantine: new preparation. Poor evaluation and uncertain benefit in Alzheimer's disease.
Prescrire Int; 2003 Dec; 12(68):203-5. PubMed ID: 14986682
[TBL] [Abstract][Full Text] [Related]
9. Early Alzheimer's disease.
Finucane TE
N Engl J Med; 2010 Oct; 363(18):1773; author reply 1773. PubMed ID: 21038515
[No Abstract] [Full Text] [Related]
10. Rationalizing therapeutic approaches in Alzheimer's disease.
Grossberg GT
CNS Spectr; 2005 Nov; 10(11 Suppl 18):17-21. PubMed ID: 16273026
[TBL] [Abstract][Full Text] [Related]
11. Retrospective study on the benefits of combined Memantine and cholinEsterase inhibitor treatMent in AGEd Patients affected with Alzheimer's Disease: the MEMAGE study.
Gareri P; Putignano D; Castagna A; Cotroneo AM; De Palo G; Fabbo A; Forgione L; Giacummo A; Lacava R; Marino S; Simone M; Zurlo A; Putignano S
J Alzheimers Dis; 2014; 41(2):633-40. PubMed ID: 24643135
[TBL] [Abstract][Full Text] [Related]
12. [Practical clinical use of therapeutic agents for Alzheimer's disease].
Arai T
Nihon Yakurigaku Zasshi; 2007 Dec; 130(6):494-8. PubMed ID: 18079601
[No Abstract] [Full Text] [Related]
13. Medical treatment of Alzheimer's disease: past, present, and future.
Ott BR
Med Health R I; 2002 Jul; 85(7):210-2. PubMed ID: 12182092
[No Abstract] [Full Text] [Related]
14. [Alzheimer dementia. Intervening as early as possible].
MMW Fortschr Med; 2002 Jan; 144(1-2):67. PubMed ID: 11847891
[No Abstract] [Full Text] [Related]
15. Drug treatment for Alzheimer's disease.
Freyne A; Cooney C
Ir Med J; 1999; 92(7):424-5. PubMed ID: 10967863
[No Abstract] [Full Text] [Related]
16. The efficacy and safety of memantine for the treatment of Alzheimer's disease.
Matsunaga S; Kishi T; Nomura I; Sakuma K; Okuya M; Ikuta T; Iwata N
Expert Opin Drug Saf; 2018 Oct; 17(10):1053-1061. PubMed ID: 30222469
[TBL] [Abstract][Full Text] [Related]
17. Rationale for combination therapy with galantamine and memantine in Alzheimer's disease.
Grossberg GT; Edwards KR; Zhao Q
J Clin Pharmacol; 2006 Jul; 46(7 Suppl 1):17S-26S. PubMed ID: 16809811
[TBL] [Abstract][Full Text] [Related]
18. A combination therapy of donepezil and cilostazol for patients with moderate Alzheimer disease: pilot follow-up study.
Arai H; Takahashi T
Am J Geriatr Psychiatry; 2009 Apr; 17(4):353-4. PubMed ID: 19307864
[No Abstract] [Full Text] [Related]
19. Benefits of combining donepezil plus traditional Japanese herbal medicine on cognition and brain perfusion in Alzheimer's disease: a 12-week observer-blind, donepezil monotherapy controlled trial.
Maruyama M; Tomita N; Iwasaki K; Ootsuki M; Matsui T; Nemoto M; Okamura N; Higuchi M; Tsutsui M; Suzuki T; Seki T; Kaneta T; Furukawa K; Arai H
J Am Geriatr Soc; 2006 May; 54(5):869-71. PubMed ID: 16696770
[No Abstract] [Full Text] [Related]
20. Commentary on "the Atorvastatin/Donepezil in Alzheimer's Disease Study (LEADe): design and baseline characteristics".
Sabbagh MN
Alzheimers Dement; 2008 May; 4(3):174-5. PubMed ID: 18631965
[No Abstract] [Full Text] [Related]
[Next] [New Search]
